Head-to-head comparisons of medication uses, side effects, warnings, and more.
Wezlana (ustekinumab or ustekinumab-auub) is a biologic medication and the first FDA-approved biosimilar to Stelara (ustekinumab). As a biosimilar, it’s approved to treat the same autoimmune conditions, including plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis. It works by blocking certain proteins called interleukins that cause inflammation in the body. The medication is usually given as an injection under the skin, with doses every 8 to 12 weeks. Common side effects include feeling tired, having a headache, or experiencing common cold symptoms.
Stelara (ustekinumab) is an injectable medication used to treat autoimmune conditions like plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis. As an interleukin antagonist, it works by blocking certain proteins that cause inflammation in your body, which helps reduce swelling and ease symptoms. You typically get it as an injection under your skin. Common side effects include common cold symptoms, headache, and feeling tired. This medication also has many biosimilars available.
Plaque psoriasis
Psoriatic arthritis
Crohn's disease
Ulcerative colitis:
Plaque psoriasis
Psoriatic arthritis
Crohn's disease
Ulcerative colitis:
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.